Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senthamil R Selvan

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|August 5, 2011
Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccinesRobert O Dillman, Gary B Fogel, Andrew N Cornforth, et al.
Melanoma Research|April 9, 2010
Establishment of stable cell lines for personalized melanoma cell vaccineSenthamil R Selvan, Denysha J Carbonell, Abner W Fowler, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 21, 2006
Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell LinesMepur H Ravindranath, Thiruverkadu S Saravanan, Clarence C Monteclaro, et al.
Biomolecules|August 26, 2023
Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?Mepur H Ravindranath, Narendranath M Ravindranath, Senthamil R Selvan, et al.
Vaccines|February 26, 2022
Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for VaccinesMepur H Ravindranath, Narendranath M Ravindranath, Senthamil R Selvan, et al.
Antibodies (Basel, Switzerland)|September 22, 2022
Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune HomeostasisMepur H Ravindranath, Fatiha El Hilali, Carly J Amato-Menker, et al.
Biochemical and Biophysical Research Communications|December 26, 2006
Immunogenic gangliosides in human ovarian carcinomaMepur H Ravindranath, Sakunthala Muthugounder, Naftali Presser, et al.
Antibodies (Basel, Switzerland)|April 24, 2023
Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under TreatmentMepur H Ravindranath, Narendranath M Ravindranath, Carly J Amato-Menker, et al.
The Prostate|October 7, 2004
Establishment and characterization of a human primary prostate carcinoma cell line, HH870Senthamil R Selvan, Andrew N Cornforth, Nagesh P Rao, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 23, 2009
Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final reportRobert O Dillman, Senthamil R Selvan, Patric M Schiltz, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Biotherapy & Radiopharmaceuticals|August 5, 2011
Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccinesRobert O Dillman, Gary B Fogel, Andrew N Cornforth, et al.
Melanoma Research|April 9, 2010
Establishment of stable cell lines for personalized melanoma cell vaccineSenthamil R Selvan, Denysha J Carbonell, Abner W Fowler, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 21, 2006
Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell LinesMepur H Ravindranath, Thiruverkadu S Saravanan, Clarence C Monteclaro, et al.
Biomolecules|August 26, 2023
Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?Mepur H Ravindranath, Narendranath M Ravindranath, Senthamil R Selvan, et al.
Vaccines|February 26, 2022
Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for VaccinesMepur H Ravindranath, Narendranath M Ravindranath, Senthamil R Selvan, et al.
Antibodies (Basel, Switzerland)|September 22, 2022
Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune HomeostasisMepur H Ravindranath, Fatiha El Hilali, Carly J Amato-Menker, et al.
Biochemical and Biophysical Research Communications|December 26, 2006
Immunogenic gangliosides in human ovarian carcinomaMepur H Ravindranath, Sakunthala Muthugounder, Naftali Presser, et al.
Antibodies (Basel, Switzerland)|April 24, 2023
Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under TreatmentMepur H Ravindranath, Narendranath M Ravindranath, Carly J Amato-Menker, et al.
The Prostate|October 7, 2004
Establishment and characterization of a human primary prostate carcinoma cell line, HH870Senthamil R Selvan, Andrew N Cornforth, Nagesh P Rao, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 23, 2009
Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final reportRobert O Dillman, Senthamil R Selvan, Patric M Schiltz, et al.
Pageof 4